Unichem Laboratories Stock Screener | Share Price & Fundamental Analysis
UNICHEMLAB
Pharmaceuticals
Screen Unichem Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹433.85
▼
-7.95 (-1.80%)
Share Price BSE
₹434.05
▼
-9.00 (-2.03%)
Market Cap
₹3,097.15 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.28
EPS (TTM)
₹19.53
Dividend Yield
-
Debt to Equity
0.14
52W High
₹740.80
52W Low
₹433.85
Operating Margin
14.00%
Profit Margin
8.89%
Revenue (TTM)
₹596.00
EBITDA
₹93.00
Net Income
₹53.00
Total Assets
₹3,569.00
Total Equity
₹2,451.00
Unichem Laboratories Share Price History - Stock Screener Chart
Screen UNICHEMLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Unichem Laboratories Company Profile - Fundamental Screener
Screen Unichem Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for UNICHEMLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE351A01035
Unichem Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen UNICHEMLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,569 | 3,275 | 3,193 | 3,319 | 3,126 | 3,145 | 3,150 | 3,194 | 1,527 | 1,284 |
| Current Assets | 2,030 | 1,743 | 1,589 | 1,648 | 1,377 | 1,687 | 2,038 | 2,337 | 749 | 600 |
| Fixed Assets | 1,300 | 1,252 | 1,257 | 990 | 884 | 870 | 810 | 578 | 491 | 403 |
| Liabilities | ||||||||||
| Total Liabilities | 3,569 | 3,275 | 3,193 | 3,319 | 3,126 | 3,145 | 3,150 | 3,194 | 1,527 | 1,284 |
| Current Liabilities | 127 | 99 | 118 | 148 | 63 | 47 | 27 | 50 | 70 | 86 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,451 | 2,438 | 2,435 | 2,618 | 2,557 | 2,531 | 2,620 | 2,680 | 1,064 | 954 |
| Share Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 18 | 18 |
| Reserves & Surplus | 2,437 | 2,424 | 2,421 | 2,604 | 2,543 | 2,517 | 2,606 | 2,666 | 1,045 | 936 |
Screen UNICHEMLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 596 | 533 | 600 | 438 | 487 | 516 | 547 | 407 | 432 | 421 | 545 | 384 | 318 | 338 | 319 |
| Expenses | 504 | 504 | 571 | 532 | 443 | 452 | 448 | 419 | 395 | 407 | 435 | 302 | 311 | 352 | 345 |
| EBITDA | 93 | 29 | 29 | -94 | 44 | 64 | 99 | -12 | 37 | 14 | 110 | 83 | 7 | -14 | -26 |
| Operating Profit % | 14.00% | 4.00% | 1.00% | -23.00% | 8.00% | 11.00% | 16.00% | -4.00% | 7.00% | 2.00% | 7.00% | 19.00% | 0.00% | -7.00% | -14.00% |
| Depreciation | 30 | 32 | 32 | 27 | 32 | 32 | 31 | 30 | 29 | 30 | 32 | 23 | 25 | 28 | 31 |
| Interest | 6 | 7 | 8 | 5 | 4 | 5 | 7 | 6 | 6 | 7 | 6 | 2 | 3 | 5 | 4 |
| Profit Before Tax | 58 | -9 | -11 | -126 | 8 | 27 | 62 | -47 | 2 | -22 | 73 | 58 | -21 | -47 | -61 |
| Tax | 5 | 1 | 1 | 3 | 6 | 3 | 4 | -3 | 3 | 3 | 0 | -14 | 3 | 23 | 3 |
| Net Profit | 53 | -11 | -12 | -129 | 2 | 25 | 58 | -44 | -1 | -25 | 73 | 72 | -23 | -71 | -64 |
| EPS | 7.52 | -1.49 | -1.69 | -18.37 | 0.29 | 3.50 | 8.22 | -6.28 | -0.09 | -3.48 | 10.39 | 10.15 | -3.32 | -10.04 | -9.08 |
Unichem Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen UNICHEMLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -7 | 14 | -85 | -260 | 33 | 20 | -328 | -112 | 68 | 112 |
| Investing Activities | -242 | 63 | 241 | 100 | -66 | -36 | -286 | 1,648 | -128 | -85 |
| Financing Activities | 184 | -106 | -81 | 191 | -121 | -62 | -2 | -881 | 59 | -33 |
| Net Cash Flow | -65 | -29 | 75 | 32 | -154 | -78 | -616 | 655 | -1 | -7 |
Screen UNICHEMLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 50.93% |
| FII Holding | 0.98% | 0.98% | 1.00% | 0.90% | 0.89% | 0.94% | 1.06% | 0.00% |
| DII Holding | 11.32% | 10.92% | 10.75% | 11.27% | 11.58% | 11.67% | 11.63% | 8.16% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 14.80% | 15.16% | 15.26% | 15.12% | 14.80% | 14.58% | 14.47% | 30.91% |
| Other Holding | 2.67% | 2.72% | 2.77% | 2.49% | 2.50% | 2.60% | 2.62% | 9.99% |
| Shareholder Count | 21,621 | 23,010 | 23,577 | 21,171 | 20,621 | 20,374 | 21,472 | 29,418 |
Unichem Laboratories Dividend Screener - Share Yield Analysis
Screen UNICHEMLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹4.00 | 0.81% |
| 2022-March | ₹4.00 | 1.39% |
| 2021-March | ₹4.00 | 1.54% |
| 2020-March | ₹4.00 | 1.29% |
| 2019-March | ₹4.00 | 2.57% |
| 2018-March | ₹5.00 | 2.57% |
| 2017-March | ₹3.00 | 1.05% |
Unichem Laboratories Index Membership - Market Screener Classification
Screen UNICHEMLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Unichem Laboratories Market Events Screener - Corporate Actions
Screen UNICHEMLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.98% |
| 2025-08-04 | 2025-08-04 | Annual General Meeting | NA | 6.72% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | 0.42% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 7.30% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 7.03% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 9.30% |
| 2024-08-08 | 2024-08-08 | Annual General Meeting | NA | 8.44% |
| 2022-08-01 | 2022-08-03 | Dividend | ₹ 4.00 /share | 26.80% |
| 2021-07-22 | 2021-07-26 | Dividend | ₹ 4.00 /share | -7.27% |
Unichem Laboratories Competitors Screener - Peer Comparison
Screen UNICHEMLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,950 | 39.35 | 54,729 | 9.71% | 10,980 | 39.47 |
| Divis Laboratories | 168,413 | 68.31 | 9,712 | 18.67% | 2,191 | 44.14 |
| Torrent Pharmaceuticals | 130,247 | 60.76 | 11,539 | 6.99% | 1,911 | 62.90 |
| Cipla | 121,238 | 22.46 | 28,410 | 7.12% | 5,291 | 46.90 |
| Dr Reddys Laboratories | 104,613 | 18.49 | 33,741 | 16.73% | 5,725 | 43.77 |
| Lupin | 96,056 | 22.19 | 22,910 | 13.74% | 3,306 | 55.44 |
| Zydus Life Science | 92,075 | 18.30 | 23,511 | 18.55% | 4,615 | 44.07 |
| Mankind Pharma | 89,356 | 51.11 | 12,744 | 20.90% | 2,007 | 44.20 |
| Aurobindo Pharma | 69,290 | 20.05 | 32,346 | 9.43% | 3,484 | 49.09 |
| Alkem Laboratories | 65,324 | 27.31 | 13,458 | 3.70% | 2,216 | 38.49 |
Unichem Laboratories Company Announcements - News Screener
Screen UNICHEMLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-27 | Closure of Trading Window | View |
| 2025-12-16 | 5Th Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 30Th November 2025. | View |
| 2025-11-17 | 4Th Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 31St October 2025. | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-11 | Financial Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-10-28 | General Update | View |
| 2025-10-15 | Board Meeting Intimation for Unaudited Financial Results (Consolidated And Standalone) For The Second Quarter And Six Months Ended September 30 2025. | View |
| 2025-10-11 | 3Rd Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 30Th September 2025. | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-06 | Intimation Of Change In Email Address Of MUFG Intime India Private Limited Registrar And Share Transfer Agent (MUFG) | View |
| 2025-10-03 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-18 | Update | View |
| 2025-09-12 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 31St August 2025. | View |
| 2025-09-03 | Update | View |
| 2025-08-26 | Unichem Laboratories Limited Received The Establishment Inspection Report (EIR) From The United States Food And Drug Administration (USFDA) | View |
| 2025-08-26 | Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-08-25 | Submission Of Advertisement Published In Newspapers Regarding Notice To Shareholder (100 DAYS CAMPAIGN - SAKSHAM NIVESHAK) For KYC And Other Related Updation And Unclaimed Dividend Due For Transfer To The Investor Education And Protection Fund (IEPF) Acco | View |
| 2025-08-05 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |